000 | 01991 a2200601 4500 | ||
---|---|---|---|
005 | 20250517004541.0 | ||
264 | 0 | _c20150127 | |
008 | 201501s 0 0 eng d | ||
022 | _a1879-0852 | ||
024 | 7 |
_a10.1016/j.ejca.2014.10.007 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMillot, Frédéric | |
245 | 0 | 0 |
_aGrowth deceleration in children treated with imatinib for chronic myeloid leukaemia. _h[electronic resource] |
260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cDec 2014 |
||
300 |
_a3206-11 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 |
_aBenzamides _xadverse effects |
650 | 0 | 4 |
_aBody Height _xdrug effects |
650 | 0 | 4 | _aBody Mass Index |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGrowth Disorders _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImatinib Mesylate |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPiperazines _xadverse effects |
650 | 0 | 4 |
_aPyrimidines _xadverse effects |
650 | 0 | 4 | _aRetrospective Studies |
700 | 1 | _aGuilhot, Joelle | |
700 | 1 | _aBaruchel, André | |
700 | 1 | _aPetit, Arnaud | |
700 | 1 | _aLeblanc, Thierry | |
700 | 1 | _aBertrand, Yves | |
700 | 1 | _aMazingue, Françoise | |
700 | 1 | _aLutz, Patrick | |
700 | 1 | _aVérité, Cecile | |
700 | 1 | _aBerthou, Christian | |
700 | 1 | _aGalambrun, Claire | |
700 | 1 | _aYacouben, Karima | |
700 | 1 | _aChastagner, Pascal | |
700 | 1 | _aGandemer, Virginie | |
700 | 1 | _aReguerre, Yves | |
700 | 1 | _aCouillault, Gérard | |
700 | 1 | _aKhalifeh, Tackwa | |
700 | 1 | _aRialland, Fanny | |
773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 50 _gno. 18 _gp. 3206-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2014.10.007 _zAvailable from publisher's website |
999 |
_c24413463 _d24413463 |